IBDEI1B2 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20870,2)
 ;;=^5050542
 ;;^UTILITY(U,$J,358.3,20871,0)
 ;;=G25.71^^95^1030^7
 ;;^UTILITY(U,$J,358.3,20871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20871,1,3,0)
 ;;=3^Medication-Induced Acute Akathisia
 ;;^UTILITY(U,$J,358.3,20871,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,20871,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,20872,0)
 ;;=G24.02^^95^1030^8
 ;;^UTILITY(U,$J,358.3,20872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20872,1,3,0)
 ;;=3^Medication-Induced Acute Dystonia
 ;;^UTILITY(U,$J,358.3,20872,1,4,0)
 ;;=4^G24.02
 ;;^UTILITY(U,$J,358.3,20872,2)
 ;;=^5003785
 ;;^UTILITY(U,$J,358.3,20873,0)
 ;;=G21.0^^95^1030^12
 ;;^UTILITY(U,$J,358.3,20873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20873,1,3,0)
 ;;=3^Neuroleptic Malignant Syndrome
 ;;^UTILITY(U,$J,358.3,20873,1,4,0)
 ;;=4^G21.0
 ;;^UTILITY(U,$J,358.3,20873,2)
 ;;=^5003771
 ;;^UTILITY(U,$J,358.3,20874,0)
 ;;=T50.905A^^95^1030^1
 ;;^UTILITY(U,$J,358.3,20874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20874,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Init Encntr
 ;;^UTILITY(U,$J,358.3,20874,1,4,0)
 ;;=4^T50.905A
 ;;^UTILITY(U,$J,358.3,20874,2)
 ;;=^5052160
 ;;^UTILITY(U,$J,358.3,20875,0)
 ;;=T50.905S^^95^1030^2
 ;;^UTILITY(U,$J,358.3,20875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20875,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Sequela
 ;;^UTILITY(U,$J,358.3,20875,1,4,0)
 ;;=4^T50.905S
 ;;^UTILITY(U,$J,358.3,20875,2)
 ;;=^5052162
 ;;^UTILITY(U,$J,358.3,20876,0)
 ;;=T50.905D^^95^1030^3
 ;;^UTILITY(U,$J,358.3,20876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20876,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,20876,1,4,0)
 ;;=4^T50.905D
 ;;^UTILITY(U,$J,358.3,20876,2)
 ;;=^5052161
 ;;^UTILITY(U,$J,358.3,20877,0)
 ;;=F45.22^^95^1031^1
 ;;^UTILITY(U,$J,358.3,20877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20877,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,20877,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,20877,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,20878,0)
 ;;=F63.3^^95^1031^7
 ;;^UTILITY(U,$J,358.3,20878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20878,1,3,0)
 ;;=3^Trichotillomania (Hair-Pulling Disorder)
 ;;^UTILITY(U,$J,358.3,20878,1,4,0)
 ;;=4^F63.3
 ;;^UTILITY(U,$J,358.3,20878,2)
 ;;=^5003643
 ;;^UTILITY(U,$J,358.3,20879,0)
 ;;=F06.8^^95^1031^5
 ;;^UTILITY(U,$J,358.3,20879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20879,1,3,0)
 ;;=3^Obsessive-Compulsive & Related Disorder d/t Another Med Condition
 ;;^UTILITY(U,$J,358.3,20879,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,20879,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,20880,0)
 ;;=F42.3^^95^1031^3
 ;;^UTILITY(U,$J,358.3,20880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20880,1,3,0)
 ;;=3^Hoarding Disorder
 ;;^UTILITY(U,$J,358.3,20880,1,4,0)
 ;;=4^F42.3
 ;;^UTILITY(U,$J,358.3,20880,2)
 ;;=^5138445
 ;;^UTILITY(U,$J,358.3,20881,0)
 ;;=F42.9^^95^1031^6
 ;;^UTILITY(U,$J,358.3,20881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20881,1,3,0)
 ;;=3^Obsessive-Compulsive Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,20881,1,4,0)
 ;;=4^F42.9
 ;;^UTILITY(U,$J,358.3,20881,2)
 ;;=^5138448
 ;;^UTILITY(U,$J,358.3,20882,0)
 ;;=F42.2^^95^1031^4
 ;;^UTILITY(U,$J,358.3,20882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20882,1,3,0)
 ;;=3^Mixed Obsessional Thoughts and Acts
 ;;^UTILITY(U,$J,358.3,20882,1,4,0)
 ;;=4^F42.2
 ;;^UTILITY(U,$J,358.3,20882,2)
 ;;=^5138444
